Australia Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Australia Insulin Delivery Devices Market is segmented into insulin pumps, insulin syringes, disposable insulin pens, insulin cartridges in reusable pens, and insulin jet injectors. The report offers the value (in USD million) and volume (in Units million) for the above segments.

Australia Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Australia Insulin Delivery Devices Market Size

Australia Insulin Delivery Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 722.45 Million
Market Size (2030) USD 813.41 Million
CAGR (2025 - 2030) 2.40 %

Major Players

Australia Insulin Delivery Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Australia Insulin Delivery Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Australia Insulin Delivery Devices Market Analysis

The Australia Insulin Delivery Devices Market size is estimated at USD 722.45 million in 2025, and is expected to reach USD 813.41 million by 2030, at a CAGR of 2.4% during the forecast period (2025-2030).

During the COVID-19 pandemic, patients with diabetes were at higher risk for hospitalizations and complications due to hyper- or hypoglycemia, metabolic comorbidities, and more severe illness from SARS-CoV-2 infection. Throughout the COVID-19 pandemic, the effects of diabetes worsened with infection and infection-induced new-onset diabetes in both adults and children. Diabetes self-management, follow-up care, and glycemic management were disrupted during the COVID-19 pandemic, which recognized the need for proper guidelines and protocols to ensure successful continuity of management and follow-up care for people with existing and new-onset diabetes.

Diabetes is a chronic condition characterized by high blood glucose levels caused by the inability to produce insulin or use insulin effectively, or both. The main types of diabetes are type 1 diabetes and type 2 diabetes. For a patient with type 1 diabetes, insulin therapy is important for replacing the insulin the body doesn't produce. People with type 2 diabetes or gestational diabetes need insulin therapy if other treatments, such as diabetes medications and other lifestyle changes, cannot keep blood glucose levels within the desired range. Diabetes treatment aims to maintain healthy blood glucose levels to prevent short- and long-term complications, such as cardiovascular disease, kidney disease, blindness, and lower limb amputation.

Diabetes has a significant and often preventable impact on the health and well-being of the Australian population. The Australian Government reviews processes and infrastructure to ensure adequate supplies and supply chains of essential medications, glucose monitoring equipment, insulin pump consumables, and measures to manage diabetes. People with diabetes who have disabilities require specialized assistance managing their diabetes, including accessing health services, administering insulin, and operating diabetes devices.

The overall CAGR is impacted by consumers switching from insulin pens and syringes to insulin pumps due to increased efficacy and patient compliance.

Australia Insulin Delivery Devices Industry Overview

The Australia Insulin Delivery Devices Market is consolidated, with few significant players. The major players such as Insulet Corporation, Ypsomed, and Novo Nordisk are working on innovations in insulin devices which is evident from the companies spending on research and developments to strengthen their market presence further.

Australia Insulin Delivery Devices Market Leaders

  1. Insulet Corporation

  2. Ypsomed

  3. Novo Nordisk A/S

  4. Medtronic

  5. Eli Lilly and Company

  6. *Disclaimer: Major Players sorted in no particular order
Australia Insulin Delivery Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Australia Insulin Delivery Devices Market News

  • November 2022: Eli Lilly and Company announced that it would roll out its first connected platform, the Tempo Personalized Diabetes Management Platform. The technology aims to help adults with type 1, or 2 diabetes and clinicians make informed, data-backed decisions to manage treatment with Lilly insulins. The platform consists of three key components - the Tempo Smart Button; a compatible app, TempoSmart; and a prefilled insulin pen, Tempo Pen- which deliver personalized guidance for adults with diabetes.
  • August 2022: Ypsomed launched bolus delivery from the smartphone on the mylife YpsoPump via the mylife App. This new feature enables mylife YpsoPump users to deliver the bolus insulin conveniently and discreetly via their smartphone without interacting with the pump itself.

Australia Insulin Delivery Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Insulin Pumps
    • 5.1.1 Insulin Pump Devices
    • 5.1.2 Insulin Pump Reservoirs
    • 5.1.3 Insulin Infusion sets
  • 5.2 Insulin Pens
    • 5.2.1 Cartridges in reusable pens
    • 5.2.2 Disposable insulin pens
  • 5.3 Insulin Syringes
  • 5.4 Insulin Jet Injectors

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population (2017 - 2028)
  • 6.2 Type-2 Diabetes population (2017 - 2028)

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Novo Nordisk
    • 7.1.2 Sanofi
    • 7.1.3 Eli Lilly
    • 7.1.4 Biocon
    • 7.1.5 Julphar
    • 7.1.6 Medtronic
    • 7.1.7 Ypsomed
    • 7.1.8 Becton Dickinson
    • 7.1.9 Insulet Corporation
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Insulet Corporation
    • 7.2.2 Novo Nordisk
    • 7.2.3 Medtronic

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Australia Insulin Delivery Devices Industry Segmentation

There are different ways to inject insulin into a patient's body, using syringes, pens, pumps, and jet injectors, giving them various options for insulin delivery. The Australia Insulin Delivery Devices Market is segmented into insulin pumps, insulin syringes, disposable insulin pens, insulin cartridges in reusable pens, and insulin jet injectors. The report offers the value (in USD million) and volume (in Units million) for the above segments.

Insulin Pumps Insulin Pump Devices
Insulin Pump Reservoirs
Insulin Infusion sets
Insulin Pens Cartridges in reusable pens
Disposable insulin pens
Need A Different Region or Segment?
Customize Now

Australia Insulin Delivery Devices Market Research FAQs

How big is the Australia Insulin Delivery Devices Market?

The Australia Insulin Delivery Devices Market size is expected to reach USD 722.45 million in 2025 and grow at a CAGR of 2.40% to reach USD 813.41 million by 2030.

What is the current Australia Insulin Delivery Devices Market size?

In 2025, the Australia Insulin Delivery Devices Market size is expected to reach USD 722.45 million.

Who are the key players in Australia Insulin Delivery Devices Market?

Insulet Corporation, Ypsomed, Novo Nordisk A/S, Medtronic and Eli Lilly and Company are the major companies operating in the Australia Insulin Delivery Devices Market.

What years does this Australia Insulin Delivery Devices Market cover, and what was the market size in 2024?

In 2024, the Australia Insulin Delivery Devices Market size was estimated at USD 705.11 million. The report covers the Australia Insulin Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Australia Insulin Delivery Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Australia Insulin Delivery Devices Industry Report

Statistics for the 2025 Australia Insulin Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Australia Insulin Delivery Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.